Delivery Order SPE2DB20D2104-SPE2DB24FS06Z
- Not listed
- This federal contract award is for the delivery of Trelegy Ellipta, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $12,130.06 firm-fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. Amerisourcebergen is a subsidiary of the parent company, Cencora, Inc., which also holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S, awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,176.39 firm fixed-price delivery order contract has a completion date of January 7, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The $2,015.75 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of September 13, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $2,417.89 firm-fixed-price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60S. The contract has an ultimate completion date of May 16, 2023. This order is part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a wide range of pharmaceutical products and...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $11,701.78 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of August 19, 2024 and was awarded on August 16, 2024. The contract is not designated with a set-aside requirement,...
- This federal contract award is for the delivery of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,351.70 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distributor. The contract has a completion date of February 15, 2024 and does not include any set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
- This federal contract award is a delivery order valued at $9,710.45 awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S medication. The award has a firm fixed price and an ultimate completion date of May 12, 2025. There is no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
- This federal contract award is for the delivery of TRELEGY ELLIPTA 100-62.5-25 60S pharmaceutical products to the Defense Logistics Agency (DLA). The $3,739.42 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a comprehensive...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,438.93 firm fixed price delivery order is for the pharmaceutical product Trelegy Ellipta 100-62.5-25 60s. The contract has an ultimate completion date of July 16, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Trelegy Ellipta 100-62.5-25 60S, a prescription medication. The $8,936.61 firm-fixed-price delivery order has an ultimate completion date of May 30, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS06ZDelivery Order
This federal contract award is for the delivery of Trelegy Ellipta, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $9,891.00 fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of January 17, 2024 and was awarded on January 16, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a smaller $750,000 IDC with the Department of Justice Federal Bureau of Investigation. These IDCs enable the company to efficiently provide a wide range of pharmaceutical products and medical supplies to support military, veteran, and federal healthcare programs. The contract award does not have a set-aside designation, indicating open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $9.9k | 1/16/24 |